These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32431269)

  • 1. Unique Characteristics of Epilepsy Development in Neurocysticercosis.
    Herrick JA; Bustos JA; Clapham P; Garcia HH; Loeb JA;
    Am J Trop Med Hyg; 2020 Aug; 103(2):639-645. PubMed ID: 32431269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG Patterns in Patients With Calcified Neurocysticercosis With or Without Hippocampal Atrophy.
    Issa NP; Sedler MJ; Del Brutto VJ; Darsan E; Milla L; Montes J; Zambrano M; Del Brutto OH
    J Clin Neurophysiol; 2018 Jul; 35(4):332-338. PubMed ID: 29649013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal Atrophy/Sclerosis Is Associated with Old, Calcified Parenchymal Brain Neurocysticercosis, But Not with More Recent, Viable Infections.
    Sánchez SS; Bustos JA; Del Brutto OH; Herrera G; Dos Santos AC; Javier Pretell E; Gonzales I; Saavedra H; Garcia HH;
    Am J Trop Med Hyg; 2021 Oct; 106(1):215-218. PubMed ID: 34695784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation of neurocysticercosis-related epilepsy.
    Duque KR; Burneo JG
    Epilepsy Behav; 2017 Nov; 76():151-157. PubMed ID: 28882721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Cysticercosis Epileptogenesis: the Role of the Hippocampus.
    Del Brutto OH; Engel J; Eliashiv DS; García HH
    Curr Neurol Neurosci Rep; 2016 Jan; 16(1):1. PubMed ID: 26659841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy.
    Bianchin MM; Velasco TR; Wichert-Ana L; Dos Santos AC; Sakamoto AC
    Epilepsy Behav; 2017 Nov; 76():168-177. PubMed ID: 28462844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From seizures to epilepsy and its substrates: neurocysticercosis.
    Singh G; Burneo JG; Sander JW
    Epilepsia; 2013 May; 54(5):783-92. PubMed ID: 23621876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocysticercosis as an infectious acquired epilepsy worldwide.
    Reddy DS; Volkmer R
    Seizure; 2017 Nov; 52():176-181. PubMed ID: 29055271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocysticercosis-related seizures: Imaging biomarkers.
    Ratcliffe C; Adan G; Marson A; Solomon T; Saini J; Sinha S; Keller SS
    Seizure; 2023 May; 108():13-23. PubMed ID: 37060627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the relationship between neurocysticercosis and mesial temporal lobe epilepsy associated with hippocampal sclerosis: coincidence or a pathogenic relationship?
    Bianchin MM; Velasco TR; Santos AC; Sakamoto AC
    Pathog Glob Health; 2012 Sep; 106(5):280-5. PubMed ID: 23265552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis.
    Bianchin MM; Velasco TR; Wichert-Ana L; Alexandre V; Araujo D; dos Santos AC; Carlotti CG; Takayanagui OM; Sakamoto AC
    Epilepsy Res; 2014 Dec; 108(10):1889-95. PubMed ID: 25306064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epilepsy, interictal EEG abnormalities and hippocampal atrophy in patients with calcified neurocysticercosis: a population study in an endemic milieu.
    Del Brutto OH; Mera RM; Wu S; Recalde BY; Issa NP
    Epileptic Disord; 2021 Apr; 23(2):357-365. PubMed ID: 33926860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilepsy and neurocysticercosis in rural Tanzania-An imaging study.
    Winkler AS; Blocher J; Auer H; Gotwald T; Matuja W; Schmutzhard E
    Epilepsia; 2009 May; 50(5):987-93. PubMed ID: 19054402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual/double pathology in neurocysticercosis causing drug resistant epilepsy - Chance association or causal?
    Mhatre R; Poyuran R; Arimappamagan A; Sinha S; Kulanthaivelu K; Kenchaiah R; Ajay A; Chowdary RM; Saini J; Bharath RD; Zanzmera P; Seetharam R; Sadashiva N; Jamuna R; Satishchandra P; Malla BR; Sk S; Anita M
    Epilepsy Res; 2020 Dec; 168():106472. PubMed ID: 33137632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis.
    Wichert-Ana L; Velasco TR; Terra-Bustamante VC; Alexandre V; Walz R; Bianchin MM; Leite JP; Assirati JA; Carlotti CG; Araújo D; Santos AC; Takayanagui OM; Sakamoto AC
    Arch Neurol; 2004 Jul; 61(7):1117-9. PubMed ID: 15262746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the relationship between calcified neurocysticercosis and epilepsy in an endemic village: A large-scale, computed tomography-based population study in rural Ecuador.
    Del Brutto OH; Arroyo G; Del Brutto VJ; Zambrano M; García HH
    Epilepsia; 2017 Nov; 58(11):1955-1961. PubMed ID: 28850668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on Neurocysticercosis-related epilepsy.
    Espino PH; Couper RG; Burneo JG
    Clin Neurol Neurosurg; 2022 Feb; 213():107139. PubMed ID: 35078088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania.
    Winkler AS; Blocher J; Auer H; Gotwald T; Matuja W; Schmutzhard E
    Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):1032-8. PubMed ID: 18571212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with symptomatic epilepsy due to neurocysticercosis.
    Zapata WR; Yang SY; Bustos JA; Gonzales I; Saavedra H; Guzman C; Pretell EJ; Garcia HH;
    Epilepsy Behav; 2022 Jun; 131(Pt A):108668. PubMed ID: 35483205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis.
    Terra-Bustamante VC; Coimbra ER; Rezek KO; Escorsi-Rosset SR; Guarnieri R; Dalmagro CL; Inuzuka LM; Bianchin MM; Wichert-Ana L; Alexandre V; Takayanagui OM; Araújo D; dos Santos AC; Carlotti CG; Walz R; Markowitsch HJ; Sakamoto AC
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1080-3. PubMed ID: 16024883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.